Same-day gonorrhea and chlamydia testing for young people
Official title: Clinical and Implementation Outcomes of a Point of Care Sexually Transmitted Infection Testing Strategy to Improve HIV Prevention Service Delivery in Adolescents
Run by Icahn School of Medicine at Mount Sinai · NCT06844045 · Data updated 2026-11-12
This project will test whether point-of-care gonorrhea and chlamydia testing helps improve HIV testing and same-day PrEP counseling and prescriptions for 16–24-year-olds in pediatric clinics.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 16 Years to 24 Years |
| Sex | All |
| Enrollment | 6460 (estimated) |
| Sponsor | Icahn School of Medicine at Mount Sinai Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Status | Recruiting |
| Started | February 24, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT06844045 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adolescents and young adults aged 16 to 24 who are receiving gonorrhea/chlamydia testing and who do not have known HIV and are not currently on PrEP.
✕Probably not a fit
Patients with known HIV infection or who already have an active PrEP prescription are excluded and would not receive direct benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial compares clinical and implementation outcomes between adolescents receiving point-of-care (POCT) gonorrhea/chlamydia testing and those receiving standard laboratory-based testing across three clinics in a large pediatric health system. Clinical outcomes include rates of HIV testing, PrEP counseling, and PrEP prescriptions, while implementation outcomes include feasibility, acceptability, and appropriateness. The design is a pragmatic, non-randomized comparison embedded in routine care to reflect real-world conditions. Investigators hypothesize POCT will increase opportunities for clinician-patient counseling, reduce loss to follow-up, and enable same-day HIV prevention service delivery.
Why it matters
Potential benefit: If successful, the approach could enable more same-day HIV prevention services and faster PrEP starts for youth, reducing missed opportunities for prevention.
How similar studies have gone: Point-of-care STI testing has improved time-to-diagnosis and treatment in other settings, but its specific effect on youth HIV testing and PrEP delivery remains less well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Patients age 16-24 years receiving POCT or lab-based GC/CT testing Exclusion Criteria: \- Patients with known HIV or active PrEP prescriptions.
Where it's running
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Sarah Wood, MD, MSHP — Mount Sinai Adolescent Health Center
- Study coordinator: Naomi Pressman, MS, RD
- Email: naomi.pressman@mountsinai.org
- Phone: (212) 731-7810
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PRP injection for female sexual function
This trial tests whether a patient’s own PRP injection into the front vaginal wall can improve sexual function in women with sexual dysfunction.
-
Dupilumab for Major Depressive Disorder
This study tests whether dupilumab can engage immune targets in adults with major depressive disorder to see if it can help with depressive symptoms.
-
Parkinson’s Risk in Gaucher Disease Type 1
This study tests how Parkinson’s risk relates to GBA1-related Gaucher disease in adults over 40, by collecting detailed clinical data and samples for future research.
-
Personalized Exercise Recommendations for Chronic Pelvic Pain
This study tests if an AI-powered, personalized exercise plan can help people with chronic pelvic pain see if tailored workouts work better than standard guidance.
-
Buprenorphine vs morphine for pain control after cesarean delivery
This study tests whether intrathecal buprenorphine provides better postcesarean pain relief than morphine for women undergoing a planned cesarean delivery.
-
SCC Deep Brain Stimulation for Bipolar Depression in Bipolar I Patients
A small study tests whether deep brain stimulation of the subcallosal cingulate can help people with bipolar I depression who have not improved with other treatments, while monitoring brain signals to watch for manic switches.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.